2020 – AMSL Diabetes

News

News and Media

News and Media
2021 2020 2019 2018
2020

Tandem Suspension Notice Update

14th December 2020 Recently the Therapeutic Goods Administration (TGA) expressed concern about the Tandem Diabetes Care t:slim X2 insulin pump. The TGA have recently issued a statement on their website which provides more information on this situation, found here. We would like to reassure everyone that we are continuing to work alongside the TGA to …

14.12.2020

Tandem Suspension Notice

24th November 2020 Recently the Therapeutic Goods Administration (TGA) expressed concern about the Tandem Diabetes Care t:slim X2 insulin pump. AMSL Diabetes and Tandem Diabetes Care have been in discussions with the TGA to address their concern. However the TGA have informed us of their intent to temporarily suspend the ARTG entry for the t:slim …

24.11.2020

Dexcom G4 PLATINUM manufactured by Dexcom – Supply Update

Dexcom G4 PLATINUM manufactured by Dexcom has been discontinued for sales directly from AMSL Diabetes.

25.09.2020

Dexcom G4 PLATINUM & Dexcom G5 Mobile Update

On the 2nd April 2020, Dexcom announced the upcoming obsolescence for Dexcom G4 PLATINUM and Dexcom G5 Mobile at dexcom.com/obsolescence. This specific announcement and timeline is only applicable to residents of the United States.

06.04.2020

Important Update: AMSL’s Commitment during COVID-19

Important Message from AMSL General Manager, Ian Slater on COVID-19 23rd March 2020 The impact of COVID-19 has been unprecedented as it continues to affect people and organisations around the world. The Federal Government, State Governments and Health Authorities continue to provide detailed guidelines on how to mitigate risks and ensure containment. We encourage all …

23.03.2020

Dexcom G6 CGM System Update

Sydney, Australia, March 2020 The Dexcom G6 Continuous Glucose Monitoring (CGM) System, has been registered in Australia (ARTG 330535).                                                                 Dexcom G6 represents the latest …

04.03.2020

The Australian Government Simplifies the Clinical Eligibility Criteria for the Continuous Glucose Monitoring (CGM) Initiative

Sydney, Australia, March 2020 The Australian Government is simplifying the clinical eligibility criteria for the Continuous Glucose Monitoring (CGM) Initiative from the 1st of March, 2020. This will allow people with type 1 diabetes under the age of 21, and those over the age of 21 who have valid concessional status to access fully subsidised CGM …

02.03.2020

Stay informed with AMSL Diabetes

Now you can get all the latest news and updates of our products, events and resources right into your inbox.

Something went wrong. Please try again later!

Send AMSL Diabetes a message

We are always happy to help, send us a message or enquiry

Back to top

php shell shell indir hacklink